BCM
FLNA

Bridgeway Capital Management’s Filana Therapeutics FLNA Stock Holding History

Bridgeway Capital Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-23,922
Closed -$49K – 1465
2018
Q2 		$49K Hold
23,922
– – ﹤0.01% 1391
2018
Q1 		$170K Hold
23,922
– – ﹤0.01% 1284
2017
Q4 		$96K Sell
23,922
-25,000
-51% -$101K ﹤0.01% 1340
2017
Q3 		$199K Hold
48,922
– – ﹤0.01% 1282
2017
Q2 		$202K Sell
48,922
-11,843
-19% -$55.9K ﹤0.01% 1289
2017
Q1 		$380K Hold
60,765
– – ﹤0.01% 1146
2016
Q4 		$243K Sell
60,765
-1,500
-2% -$6.96K ﹤0.01% 1276
2016
Q3 		$436K Hold
62,265
– – 0.01% 1146
2016
Q2 		$955K Buy
62,265
+14,286
+30% +$227K 0.01% 802
2016
Q1 		$749K Hold
47,979
– – 0.01% 890
2015
Q4 		$588K Buy
47,979
+700
+1% +$9.26K 0.01% 991
2015
Q3 		$606K Buy
47,279
+10,200
+28% +$129K 0.01% 945
2015
Q2 		$449K Buy
37,079
+2,743
+8% +$37.6K 0.01% 1122
2015
Q1 		$454K Sell
34,336
-17,443
-34% -$235K 0.01% 1134
2014
Q4 		$736K Buy
51,779
+14,286
+38% +$247K 0.02% 894
2014
Q3 		$1.03M Sell
37,493
-100
-0.3% -$3.04K 0.03% 742
2014
Q2 		$1.51M Buy
37,593
+100
+0.3% +$3.7K 0.04% 605
2014
Q1 		$1.44M Hold
37,493
– – 0.04% 610
2013
Q4 		$1.28M Buy
37,493
+357
+1% +$9.48K 0.04% 656
2013
Q3 		$707K Buy
37,136
+10,771
+41% +$188K 0.02% 865
2013
Q2 		$408K Buy
+26,365
New +$557K 0.02% 1033

Other funds holding FLNA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Bridgeway Capital Management's FLNA Position: Q3 2018 in Review

Bridgeway Capital Management sold out of Filana Therapeutics (FLNA) in Q3 2018, closing a stake of 23,922 shares — an estimated $49K sold.

Bridgeway Capital Management first reported a position in FLNA in Q2 2013 and held it in 21 quarters. The position peaked at $1.51M in Q2 2014. 25 funds tracked by Wall St. Rank hold FLNA as of Q3 2018.

  • Bridgeway Capital Management reported no remaining Filana Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Bridgeway Capital Management sold 23,922 Filana Therapeutics shares in Q3 2018, an estimated $49K.
  • Bridgeway Capital Management first reported a position in Filana Therapeutics in Q2 2013 and held it in 21 quarters.
  • Bridgeway Capital Management's Filana Therapeutics position peaked at $1.51M in Q2 2014.
  • 25 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2018.

Based on Bridgeway Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.